Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Nektar Therapeutics (NASDAQ: NKTR) was $0.82 for the day, down -0.10% from the previous closing price of $0.82. In other words, the price has decreased by -$0.10 from its previous closing price. On the day, 1.32 million shares were traded.
Ratios:
Our analysis of NKTR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.24 and its Current Ratio is at 4.24. In the meantime, Its Debt-to-Equity ratio is 4.22 whereas as Long-Term Debt/Eq ratio is at 3.78.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $4.
On December 10, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $6.50.
On November 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $7.Piper Sandler initiated its Overweight rating on November 04, 2024, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 19 ’25 when Zalevsky Jonathan sold 10,300 shares for $1.01 per share. The transaction valued at 10,403 led to the insider holds 316,604 shares of the business.
Wilson Mark Andrew sold 11,040 shares of NKTR for $11,150 on Feb 19 ’25. The Chief Legal Officer now owns 324,292 shares after completing the transaction at $1.01 per share. On Feb 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,774 shares for $1.01 each. As a result, the insider received 24,012 and left with 1,086,901 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.62 while its Price-to-Book (P/B) ratio in mrq is 3.09.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $1.93, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -7.76%, while the 200-Day Moving Average is calculated to be -29.07%.
Shares Statistics:
A total of 184.46M shares are outstanding, with a floating share count of 177.79M. Insiders hold about 3.62% of the company’s shares, while institutions hold 70.10% stake in the company.
